Publications by authors named "F Hunstig"

Snakebite envenoming (SBE) is a neglected tropical disease (NTD). Community-based studies from sub-Saharan Africa are urgently required as data on the incidence are scarce. This study aimed to determine the lifetime prevalence of snakebites in rural Gabon by preparing the conduct of a larger regional survey.

View Article and Find Full Text PDF

African tick bite fever, an acute febrile illness, is caused by the obligate intracellular bacterium Rickettsia africae. Immune responses to rickettsial infections have so far mainly been investigated in vitro with infected endothelial cells as the main target cells, and in mouse models. Patient studies are rare and little is known about the immunology of human infections.

View Article and Find Full Text PDF

Myeloid sarcoma (MS) as a solid extra-medullary (EM) manifestation of acute myeloid leukemia (AML), myeloproliferative or myelodysplastic syndromes is a rare presentation of relapse after allogeneic hematopoietic stem cell transplantation (HSCT). The databases of the Departments of Hematology and Oncology of the University Hospitals of Jena and Rostock were screened for patients aged 18 years or older for onset of MS after HSCT for myeloid malignancies between 2002 and 2019. Nineteen patients with MS were identified, the majority of whom had received reduced-intensity conditioning (RIC).

View Article and Find Full Text PDF

Infectious complications such as invasive aspergillosis or infection with (SM) in immunocompromised patients are associated with a high mortality rate. Our report concerns a 40-year-old male newly diagnosed very severe aplastic anemia (vSAA) who in consequence of a mosquito bite was suffering from skin lesion and consecutive soft tissue phlegmon subsequent to the administration of antithymocyte globulin; a full-thickness autologous meshed skin graft successfully performed to cover skin ulcera after allogeneic stem cell transplantation (SCT). This unusual case illustrates the importance of appropriate diagnosis, anti-infective therapy and close interdisciplinary diagnostic algorithms to minimalize side effects and the selection of resistant strains and to improve patients' outcome.

View Article and Find Full Text PDF
Article Synopsis
  • CMV (cytomegalovirus) infection can lead to serious health issues after allogeneic hematopoietic stem cell transplants (HSCT), and letermovir (LMV) is a new drug approved for preventing these infections.
  • A case study of a 60-year-old woman post-HSCT revealed that she experienced CMV reactivation despite using LMV, which was switched to foscarnet due to complications and then back to LMV.
  • The patient's condition worsened due to a mutation in the CMV virus that caused resistance to LMV, highlighting the need for doctors to be aware of risk factors for drug-resistant infections, even with medications that have good side effect profiles.
View Article and Find Full Text PDF